{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T03:44:46Z","timestamp":1765079086222},"reference-count":27,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[1994,1,1]],"date-time":"1994-01-01T00:00:00Z","timestamp":757382400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[1994,1]]},"DOI":"10.1016\/s0168-8278(05)80388-5","type":"journal-article","created":{"date-parts":[[2005,6,17]],"date-time":"2005-06-17T15:23:56Z","timestamp":1119021836000},"page":"151-158","source":"Crossref","is-referenced-by-count":39,"title":["Lymphocyte reactivity to ex-vivo drug antigens in drug-induced hepatitis"],"prefix":"10.1016","volume":"21","author":[{"given":"Vasco A.J.","family":"Maria","sequence":"first","affiliation":[]},{"given":"Ligia","family":"Pinto","sequence":"additional","affiliation":[]},{"given":"Rui M.M.","family":"Victorino","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S0168-8278(05)80388-5_bib1","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/S0140-6736(86)92144-6","article-title":"The spectrum of hepatotoxicity due to drugs","volume":"ii","author":"Sherlock","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/S0168-8278(05)80388-5_bib2","first-page":"555","article-title":"The liver. Its role in drug biotransformation and as target of immunologic injury","volume":"11","author":"Wilson","year":"1991","journal-title":"Immunol Allergy Clin N Am"},{"key":"10.1016\/S0168-8278(05)80388-5_bib3","doi-asserted-by":"crossref","first-page":"706","DOI":"10.4049\/jimmunol.149.2.706","article-title":"Drug-specific T cells derived from patients with drug-induced allergic hepatitis","volume":"149","author":"Tsutsui","year":"1992","journal-title":"J Immunol"},{"key":"10.1016\/S0168-8278(05)80388-5_bib4","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/BF00555505","article-title":"The specificity of the lymphocyte transformation test in a patient with hypersensitivity reactions to pyrazolone compounds. A 10-week follow-up study before and after rechallenge","volume":"35","author":"Brattig","year":"1988","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/S0168-8278(05)80388-5_bib5","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1001\/jama.1973.03220320028008","article-title":"Lymphocyte transformation. Absence of increased responses in alleged halothane jaundice","volume":"225","author":"Walton","year":"1973","journal-title":"J Am Med Assoc"},{"key":"10.1016\/S0168-8278(05)80388-5_bib6","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1001\/archinte.141.13.1797","article-title":"Evaluation of prajmalium-induced cholestasis by immunological tests","volume":"141","author":"Rotmensch","year":"1981","journal-title":"Arch Intern Med"},{"key":"10.1016\/S0168-8278(05)80388-5_bib7","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1146\/annurev.pa.28.040188.002055","article-title":"The immunologic and metabolic basis of drug hypersensitivities","volume":"28","author":"Pohl","year":"1988","journal-title":"Ann Rev Pharmacol"},{"key":"10.1016\/S0168-8278(05)80388-5_bib8","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1056\/NEJM198508223130803","article-title":"The role of metabolite-specific antibodies in nomifensine-dependent immune hemolytic anemia","volume":"313","author":"Salama","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1016\/S0168-8278(05)80388-5_bib9","series-title":"Drug Reactions and the Liver","first-page":"105","article-title":"Role of immune mechanisms in drug induced diseases","author":"Berg","year":"1981"},{"key":"10.1016\/S0168-8278(05)80388-5_bib10","first-page":"792","article-title":"Nachweis von Arzneimittel-allergien mit Hilfe das Lymphozyten-transformationstests","volume":"12","author":"Berg","year":"1983","journal-title":"Klinikarzt"},{"key":"10.1016\/S0168-8278(05)80388-5_bib11","first-page":"177","article-title":"Modifications of the lymphocyte transformation test in a case of drug-induced cholestatic hepatitis","author":"Victorino","year":"1985","journal-title":"Diagn. Immunol"},{"key":"10.1016\/S0168-8278(05)80388-5_bib12","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/S0140-6736(86)91187-6","article-title":"Drug-induced hepatitis and lymphocyte transformation test in presence of prostaglandin inhibitor","volume":"i","author":"Victorino","year":"1986","journal-title":"lancet"},{"key":"10.1016\/S0168-8278(05)80388-5_bib13","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/0090-1229(80)90024-0","article-title":"Regulation of the immune response by prostaglandins","volume":"15","author":"Goodwin","year":"1980","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/S0168-8278(05)80388-5_bib14","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1084\/jem.146.6.1719","article-title":"Suppression of T cell mitogenesis by prostaglandin: existence of a prostaglandin producing suppressor cell","author":"Goodwin","year":"1977","journal-title":"J Exp Med"},{"key":"10.1016\/S0168-8278(05)80388-5_bib15","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1056\/NEJM198004103021503","article-title":"Antigen specific suppressor cells and suppressor factors in human filariasis with Brugia malayi","volume":"302","author":"Piessens","year":"1980","journal-title":"N Engl J Med"},{"key":"10.1016\/S0168-8278(05)80388-5_bib16","first-page":"1639","article-title":"Modulation of the host response in human schistosomiasis. Adherent suppressor cells that inhibit lymphocyte proliferation responses to parasite antigens","volume":"123","author":"Ottensen","year":"1979","journal-title":"J Immunol"},{"key":"10.1016\/S0168-8278(05)80388-5_bib17","series-title":"Drug-induced hepatic injury","first-page":"21","article-title":"Diagnosis and analysis of drug-induced hepatic injury","author":"Stricker","year":"1985"},{"key":"10.1016\/S0168-8278(05)80388-5_bib18","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1056\/NEJM197711032971802","article-title":"Prostaglandin producing suppressor cells in Hodgkin's disease","volume":"297","author":"Goodwin","year":"1977","journal-title":"N Engl J Med"},{"key":"10.1016\/S0168-8278(05)80388-5_bib19","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1001\/archinte.1987.00370050179030","article-title":"Floxacillin-induced cholestatic hepatitis with evidence of lymphocyte sensitization","volume":"147","author":"Victorino","year":"1987","journal-title":"Arch Intern Med"},{"key":"10.1016\/S0168-8278(05)80388-5_bib20","first-page":"197","article-title":"Indomethacin sensitive suppressor cells in Crohn's disease: a possible role in decreased lymphocyte responsiveness","volume":"11","author":"Victorino","year":"1983","journal-title":"J Clin Lab Immunol"},{"key":"10.1016\/S0168-8278(05)80388-5_bib21","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/0168-8278(89)90147-5","article-title":"Detection of antibodies to a halothane metabolite hapten in sera from patients with halothane-associated hepatitis","volume":"9","author":"Bird","year":"1989","journal-title":"J Hepatol"},{"key":"10.1016\/S0168-8278(05)80388-5_bib22","first-page":"624P","article-title":"The detection of anti-amodiaquine antibodies by ELISA","volume":"26","author":"Christie","year":"1988","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/S0168-8278(05)80388-5_bib23","doi-asserted-by":"crossref","first-page":"58S","DOI":"10.1007\/BF01538132","article-title":"Role of eicosanoids in human and experimental colitis","author":"Schumert","year":"1988","journal-title":"Dig Dis Sci"},{"key":"10.1016\/S0168-8278(05)80388-5_bib24","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1365-2249.1992.tb06426.x","article-title":"Evidence for prostaglandin producing suppressor cells in drug induced liver injury and implications in the diagnosis of drug sensitization","volume":"87","author":"Victorino","year":"1992","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/S0168-8278(05)80388-5_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0163-7258(90)90006-N","article-title":"Molecular genetics of the P-450 superfamily","volume":"45","author":"Gonzalez","year":"1990","journal-title":"Pharmacol Ther"},{"key":"10.1016\/S0168-8278(05)80388-5_bib26","article-title":"Lymphocyte proliferation to drugs: analysis of the value of a 24 well lymphocyte culture system","author":"Maria","year":"1993","journal-title":"Toxicology in vitro"},{"key":"10.1016\/S0168-8278(05)80388-5_bib27","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/BF01713174","article-title":"Indoprofen-induced aplastic anemia in active connective tissue disease detected by drug-specific lymphocyte transformation","volume":"64","author":"Saal","year":"1986","journal-title":"Klin Wochenschr"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827805803885?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827805803885?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,26]],"date-time":"2024-01-26T23:27:51Z","timestamp":1706311671000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827805803885"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994,1]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1994,1]]}},"alternative-id":["S0168827805803885"],"URL":"https:\/\/doi.org\/10.1016\/s0168-8278(05)80388-5","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[1994,1]]}}}